Remdesivir all set to be first COVID-19 therapy
26 Jun 2020
Doctors in Europe will soon be able to treat COVID-19 patients with Gilead’s antiviral drug, Remdesivir, after the healthcare regulator’s endorsement put it on track to become the first therapy for the disease on the continent.